Secondary included amines, carbonyl compounds, indolyl carboxylic acids, keto acids and phenyl propylamines (Fig
Synthetic Growth Hormone-Releasing Peptides (GHRPs): A Historical Appraisal of the Evidences Supporting Their Cytoprotective Effects
These are especially problematic when GLP-1 medications have already reduced your gut motility
Given the pre-existing data on GLP-1 and glucagon, we designed a double-blinded randomised cross-over study, in which we gave volunteers who were overweight short-term intravenous infusions of glucagon (50 ng/kg/min or 14 pmol/kg/min), GLP-1 (0.8 pmol/kg/min), combination of glucagon + GLP-1 at the same doses, or placebo over 45 minutes, and demonstrated that there was a significant increase in resting energy expenditure with glucagon alone which was preserved with the combination of glucagon + GLP-1, whereas GLP-1 did not affect energy expenditure (66)
[DOI] [PubMed] [Google Scholar] 89.Zaccheo T, Giudici D, Panzeri A, di Salle E
Hormonal shifts can influence it, but so can vaginal dryness, discomfort during intimacy, stress, emotional fatigue, and changes in tissue health